help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2003-1431
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schulz, C.
Right arrow Articles by Lehnert, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schulz, C.
Right arrow Articles by Lehnert, H.
Endocrinology Vol. 145, No. 6 2696-2701
Copyright © 2004 by The Endocrine Society

Central Nervous and Metabolic Effects of Intranasally Applied Leptin

Carla Schulz, Kerstin Paulus and Hendrik Lehnert

Department of Endocrinology and Metabolism, Magdeburg University Medical School, Otto-von-Guericke University Magdeburg, 39120 Magdeburg, Germany

Address all correspondence and requests for reprints to: Dr. C. Schulz, Department of Endocrinology and Metabolism, Magdeburg University Medical School, 39120 Magdeburg, Germany. E-mail: carla. schulz{at}medizin.uni-magdeburg.de.

In obesity, due to the resistance of leptin receptors at the blood brain barrier, increased peripheral leptin levels cannot act appropriately at brain sites relevant for appetite regulation. In this study, we focused on the intranasal application of leptin. This mode of administration provides a promising tool for a direct access of peptides to the brain by circumventing the blood brain barrier. Male Wistar rats were treated daily with 0.1 or 0.2 mg/kg leptin intranasally for 4 wk. Compared with controls, leptin-treated animals gained significantly less weight and exhibited significantly reduced food and water intake. Corticotropin-releasing factor mRNA expression in the paraventricular nucleus showed a tendency for up-regulation by leptin; neuropeptide Y mRNA expression in the arcuate nucleus was decreased. In the central nucleus of the amygdala, corticotropin-releasing factor mRNA was significantly elevated in leptin-treated animals, suggesting a role in affective and/or emotional aspects of food intake. Serum leptin levels were unchanged, indicating a direct action of leptin in the central nervous system without prior access to the periphery. The intranasal application thus represents a useful tool to administer leptin in a noninvasive way with rapid permeation into the central nervous system.




This article has been cited by other articles:


Home page
Appl. Environ. Microbiol.Home page
L. G. Bermudez-Humaran, S. Nouaille, V. Zilberfarb, G. Corthier, A. Gruss, P. Langella, and T. Issad
Effects of Intranasal Administration of a Leptin-Secreting Lactococcus lactis Recombinant on Food Intake, Body Weight, and Immune Response of Mice
Appl. Envir. Microbiol., August 15, 2007; 73(16): 5300 - 5307.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Fliedner, C. Schulz, and H. Lehnert
Brain Uptake of Intranasally Applied Radioiodinated Leptin in Wistar Rats
Endocrinology, May 1, 2006; 147(5): 2088 - 2094.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society